Microgyon® Fe Oral Contraceptive
Microgynon® Fe Oral Contraceptive Available and Affordable in Nigeria
Bayer Healthcare and USAID Partner to make Microgynon® Fe Oral Contraceptive Available and Affordable in Nigeria
The Microgynon® Fe brand is the world’s most widely used oral contraceptive. The reduced price enables middle-income couples to access a quality, affordable family planning product.
The partnership is designed to make more affordable family planning choices available to women through the private sector and address the growing demand for contraceptives and the overall sustainability of supply. Family planning allows couples to plan their families as they desire, reduces the risks from unintended and/or high-risk pregnancies, and improves the health of mothers and their children by allowing time between pregnancies.
After the introduction Microgynon® Fe in Ethiopia, Uganda, Tanzania, Malawi, Rwanda, Ghana, and Kenya, the Bayer-USAID partnership will expand the initiative to several more Sub-Saharan countries by 2016. USAID Nigeria’s Director, Health, Population and Nutrition office, Dr. Nancy Lawenthal, emphasized the importance of public-private partnerships in helping governments meet their Millennium Development Goals (MDGs). “We are pleased that this important initiative between USAID and Bayer Healthcare is being extended to Nigeria. The private sector has an important role to play in contributing to sustainable development and in this case, by ensuring that Nigerian women have access to a sustainable supply of quality, affordable oral contraceptives.”
“Combined oral contraceptives are 99% effective when used consistently and correctly. It also provides women with a reversible method that is easy to discontinue and has a rapid return to fertility. Microgynon® Fe is being used by millions of women around the world and is well known and trusted by medical professionals,” said Dr. O.I. Akinola, Obstetrician/Gynecologist, and President of the Society of Gynecology & Obstetrics of Nigeria (SOGON)
Women interested in finding out more information about Microgynon® Fe should talk with their nearest private healthcare provider.
Microgynon® Fe is manufactured in Germany by Bayer HealthCare and imported to Nigeria by CHI Pharmaceuticals.
Microgynon® Fe is now available in local pharmacies at a significantly lower price after its recent launch on the 18th of June, 2015 at The Sheraton Hotels Abuja, Nigeria. The product comes as a result of an innovative public-private partnership between Bayer Health Care (www.healthcare.bayer.com) and the United States Agency for International Development (USAID) www.usaid.gov
For more information, contact
Managing Director Ulrike Schroeder
CHI Pharmaceuticals Ltd. Corporate Communications
14, Chivita Avenue, Ajao Estate Bayer Pharma AG, Berlin – Germany
Apakun – Oshodi, Lagos – Nigeria Phone: +49 30 468 192296
Lagos – Nigeria Email: Ulrike.email@example.com